You are here

  • Home
  • Archive
  • Volume 1, Issue Suppl 1
  • ADXS11-001 immunotherapy targeting HPV-E7: updated survival and safety data from a phase 2 study in Indian women with recurrent/refractory cervical cancer

Article metrics

Article menu

Download PDFPDF

Poster Presentation
ADXS11-001 immunotherapy targeting HPV-E7: updated survival and safety data from a phase 2 study in Indian women with recurrent/refractory cervical cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to October 2024

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020042
Mar 2020010
Apr 2020071
May 202001115
Jun 20200531
Jul 2020050
Aug 2020010
Sep 2020090
Oct 2020010
Nov 2020020
Dec 2020030
Jan 2021050
Feb 2021041
Mar 2021021
Apr 2021051
May 2021020
Jun 2021070
Jul 2021020
Aug 2021014
Sep 2021031
Oct 2021081
Nov 2021075
Dec 2021070
Jan 2022082
Feb 2022032
Mar 2022071
Apr 20220102
May 20220231
Jun 20220181
Jul 20220135
Aug 20220112
Sep 20220131
Oct 20220150
Nov 202201110
Dec 2022040
Jan 2023091
Feb 20230290
Mar 2023061
Apr 2023010
May 2023020
Jun 2023041
Jul 2023041
Aug 2023040
Sep 2023040
Oct 2023052
Nov 2023081
Dec 2023061
Jan 20240103
Feb 2024061
Mar 20240528
Apr 20240817
May 20240114
Jun 2024082
Jul 20240135
Aug 2024030
Sep 2024043
Oct 2024092
Total0449134